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Gestational diabetes mellitus (gdm) is defined as any degree of glucose intolerance with onset or first recognition during preg- 
nancy.1 GDM complicates about 2.7–27% of all preg- 
nancies, varying according to a population’s composition 
and the diagnostic criteria used.2,3 GDM has a profound 
association with maternal and neonatal complications. 
In the short term, pregnant women with GDM are at 
higher risk of developing pregnancy-induced hypertension 
and requiring a Caesarean section (CS). Moreover, women 
with GDM are at an increased risk of GDM in future 
pregnancies and also at a higher risk of developing type 
2 diabetes mellitus (T2DM) in the future.4,5 GDM has 
also been associated with neonatal complications such 
as macrosomia, shoulder dystocia, birth trauma, hypo- 
glycaemia, respiratory distress syndrome, polycythaemia 
and jaundice.3 Furthermore, GDM in pregnant women 
increases the risk of obesity and glucose intolerance in 
their children.6 GDM is therefore an important public 
health issue that has major repercussions for both mother 
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اإلسرتاتيجيات غري الطبية لتحسني نتائج احلمل يف النساء املصابات بسكري احلمل
مراجعة األدبيات
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abstract: This review aimed to examine the literature related to non-medical strategies used to improve pregnancy 
outcomes of women with gestational diabetes mellitus (GDM) and to determine the risk of bias of the selected 
studies. Treatment for GDM is changing due to the increased prevalence of GDM-related maternal and neonatal 
complications. A growing body of evidence suggests that early detection, aggressive monitoring and management of 
GDM using non-medical strategies can greatly improve outcomes for pregnant women and their babies. PubMed® 
(National Library of Medicine, Bethesda, Maryland, USA), Cumulative Index to Nursing and Allied Health Literature® 
(EBSCO Information Services, Ipswich, Massachusetts, USA), SCOPUS® (Elsevier, Amsterdam, Netherlands) and 
other electronic databases were searched for relevant literature published between 2005–2015. A total of 15 studies 
on women with GDM that met the inclusion criteria were included in this review and assessment of risk of bias 
was performed for each study. The results of the studies were consistent with findings of significant improvement 
in maternal and neonatal outcomes when diet was combined with moderate exercise, self-monitoring of blood 
glucose and individualised health education. Future intervention studies in this area should be focussed on ident- 
ifying and implementing factors that enhance and encourage adherence to the healthy behaviours mentioned above. 
Keywords: Pregnancy Outcomes; Maternal Health; Neonatal Health; Health Behaviors; Gestational Diabetes Mellitus.
امللخ�ص: يهدف هذا الإ�ستعرا�ض اإىل درا�سة الأدبيات املتعلقة بالإ�سرتاتيجيات غري الطبية امل�ستخدمة لتح�سني نتائج احلمل بني الن�ساء 
ب�سبب  وذلك   م�ستمر  تغري  احلمل يف  �سكري  اأن عالج  املعروف  من  املختارة.  للدرا�سات  التحيز  احلمل وحتديد خطر  ب�سكري  امل�سابات 
زيادة اإنت�سار امل�ساعفات املتعلقة ب�سكري احلمل يف الأمهات واملواليد. وت�سري جمموعة متزايدة من الأدلة اإىل اأن الك�سف املبكر والإدارة 
الفعالة ل�سكري احلمل باإ�ستخدام اإ�سرتاتيجيات غري طبية ميكن اأن يح�سن كثريا من النتائج بالن�سبة للحوامل واأطفالهن. مت البحث يف قواعد 
البيانات عن الأدبيات ذات ال�سلة واملن�سورة بني 2005-2015 يف امل�سادر الأكرتونية ®PubMed )املكتبة الوطنية للطب، بيثادا، مرييالند، 
الوليات المريكيه(، والفهر�ض الرتاكمي للتمري�ض والأدب ال�سحي املتحالفة ®EBSCO )خدمات املعلومات، ايب�سويت�ض، ما�سات�سو�ست�ض(، 
®SCOPUS )�سكوب�ض، ال�سيفري، اأم�سرتدام، هولندا( وم�سادر اإلكرتونيه اأخرى. و قد مت يف هذا الإ�ستعرا�ض اإدراج جمموع 15 درا�سة م�ستوفية 
ملعايري ال�سمول ومت تقييم خماطر التحيز لكل درا�سة. وكانت نتائج الدرا�سات مت�سقة مع نتائج التح�سن الكبري يف النتائج بالن�سبة لالأمهات 
لالأمهات احلوامل واأطفالهن عندما مت اجلمع بني النظام الغذائي مع ممار�سة ن�ساط ج�سماين معتدل، والر�سد الذاتي لل�سكر يف الدم والتعليم 
ال�سحي  الفردي. لذلك ينبغي اأن تركز درا�سات التدخل املقبلة يف هذا املجال على حتديد وتنفيذ العوامل التي تعزز وت�سجع التقيد بال�سلوكيات 
ال�سحية املذكورة اأعاله خالل فرتة احلمل.
الكلمات املفتاحية: نتائج احلمل؛ �سحة الأم؛ �سحة حديثى الولدة؛ ال�سلوكيات ال�سحية؛ �سكري احلمل.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
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and offspring. GDM is preventable and, even after onset, 
if detected early can be reversible. Therefore, early det- 
ection of GDM provides a window of opportunity to 
intervene and reduce adverse perinatal outcomes.7 
The treatment of choice for GDM includes medical 
and non-medical interventions. Medical interventions 
include oral hypoglycaemic agents and insulin therapy. 
Although insulin therapy traditionally has been the first- 
line treatment, it is not without its challenges.8 Non-
medical interventions are recommended as first-line 
treatments and involve self-care through lifestyle modif- 
ications (typically diet and exercise) and self-monitoring 
of blood glucose levels (SMBG).9 Therefore, the purpose 
of this literature review was to investigate non-medical 
strategies used to treat GDM in order to improve preg- 
nancy outcomes. 
Literature Review
A literature search was performed using PubMed® (Nat- 
ional Library of Medicine, Bethesda, Maryland, USA), 
Cumulative Index to Nursing and Allied Health Litera- 
ture® (EBSCO Information Services, Ipswich, Massa- 
chusetts, USA) and SCOPUS® (Elsevier, Amsterdam, 
Netherlands) to retrieve all peer-reviewed articles publ- 
ished between 2005–2015. Abstracts were screened by 
at least two investigators using the following inclusion 
criteria: the article had to be published in a peer-reviewed 
journal between 2005–2015; written in English; involved 
human female subjects in the reproductive age group; 
and have the primary aim of assessing different strat- 
egies or interventions in decreasing the incidence of at 
least one GDM-related complication among women with 
GDM. Keywords used included “educational non-medical 
strategies”, “improved pregnancy outcomes”, “treatment”, 
“pregnancy”, “GDM”, “gestational diabetes”, “life-style”, 
“diet”, “exercise”, “maternal outcomes” and “neonatal 
outcomes”. 
The literature search identified 15 studies that met 
the review’s inclusion criteria [Table 1]. In the reviewed 
articles, the intervention group received a combination 
of strategies or a single strategy that was compared to a 
control group. Seven studies reported effects of particular 
dietary advice, one trial described the impact of regular 
exercise and five studies evaluated a combination of diff- 
erent lifestyle modifications involving both diet and 
exercise.10–22 Moreover, one study examined vitamin D 
supplementation and one evaluated probiotics supple- 
mentation.23,24 Insulin treatment was considered in most 
studies if the glycaemic target was not achieved after 
using other strategies. Assessment of risk of bias was 
performed for each study by considering eight domains: 
1) randomisation of participants; 2) whether the study 
was double-blinded; 3) sample size power; 4) the use of 
appropriate statistical analyses; 5) an adequate intervention 
period; 6) managed violations in assumptions of statist- 
ical tests; 7) whether the study was controlled for con- 
founding factors; and 8) controlled for co-intervention. 
Each domain was assigned one point, where a total score 
≥5 indicated low-to-moderate risk of bias and a total 
score of <5 indicated a moderate-to-high risk of bias. 
Effectiveness of Dietary 
Strategies
Seven experimental studies evaluated the effectiveness 
of various dietary strategies—included a low-sodium 
diet, a low-to-moderate carbohydrate diet, a low-gly- 
caemic index (LGI) diet and a high-fibre (HF) diet—for 
improving maternal and neonatal outcomes in women 
with GDM.10–16 Five studies implementing dietary strat- 
egies demonstrated statistically significant reductions 
in the incidence of at least one GDM-related compl-
ication.10,12,13,15,16
A detailed investigation of these studies revealed 
various outcomes. Asemi et al.’s 2014 randomised contr- 
olled trial (RCT) revealed that consuming a low-sodium 
diet (2,400 mg/day) for four weeks was associated with 
significantly lower CS risks and macrosomia rates and 
less need for insulin treatment.11 The low-sodium diet 
included fruits, vegetables, whole grains, low-fat dairy 
products and reduced amounts of saturated fats. Similarly, 
Landon et al. conducted a single-blinded RCT and found 
that a combination of dietary counselling, nutrition 
therapy and SMBG were significantly associated with 
reduced rates of pre-eclampsia, CS, macrosomia and 
the likelihood of babies being large for gestational age 
(LGA). Furthermore, the intervention group exper-
ienced significantly lower weight gain compared to the 
control group (P <0.001).14 Unfortunately, specific dietary 
recommendations were not reported in this study. 
A study with a quasi-experimental design cond- 
ucted by Perichart-Perera et al. found that the risk of 
having a baby with low birth weight (<2,500 g) was sig- 
nificantly lower among women with GDM who had 
received medical nutrition intervention versus those 
in the control group (P = 0.041).16 Medical nutrition 
therapy consisted of moderate carbohydrate intake 
(40–45%), SMBG and individual nutrition counselling. 
Compliance rates were acceptable and 73.1% of the 
intervention participants were adherent to the recomm- 
ended dietary advice.16 A double-blinded RCT conducted 
by Crowther et al. reported that women with GDM 
who received individualised dietary advice and instruc- 
tions about SMBG had a significant reduction in the 
incidence of serious perinatal adverse effects—including 
neonatal death, shoulder dystocia, bone fracture and 
nerve palsy—compared to women who received routine 
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Table 1: Summary of selected studies evaluating the non-medical strategies used to improve pregnancy outcomes of 




Odar et al.10 
(2004)
• No significant difference between intervention and control groups for requiring insulin therapy, average Apgar 
scoreat five minutes, rate of induction of labour, rate of CS, rate of macrosomia, rate of neonatal admission to NICU, 
rate of pre-eclampsia or pregnancy induced hypertension and rate of LGA (P ≥0.10).
Asemi et al.11 
(2014) 
• The DASH group had a significant reduction in CS rate, macrosomia rate and need for insulin therapy compared 
to the control group (P ≤0.01). 
• No significant difference was found for newborn length,Apgar score at five minutes, incidence of polyhydramnios 
and mean gestational age (P ≥0.31).
Moreno-
Castilla et al.12 
(2013) 
• Maternal weight gain was significantly higher in the control group (2.1 kg) than the low-CHO group (1.1 kg; P = 0.017). 
• No significant difference was found for average gestational age at delivery, incidence of ketonuria or rates of CS, 
macrosomia, newborn hypoglycaemia or insulin treatment (P ≥0.2).
Crowther et al.13 
(2005)
• The intervention group had a significantly higher rate of NICU admission and induction of labour compared to the 
control group (P ≤0.01). 
• No significant difference was found for neonatal death, stillbirth, neonatal bone fracture, nerve palsy, neonatal 
jaundice requiring phototherapy and the need for either elective or emergency CS (P ≥0.11).
Landon et al.14 
(2009)
• No significant difference was found between the intervention and control groups for the average gestational age at 
birth, rate of neonatal jaundice, neonatal hypoglycaemia, birth trauma, preterm delivery, respiratory distress syndrome 
or neonatal admission to NICU (P ≥0.12). 
• A significant difference was found for reduced birth weight, macrosomia rate, LGA, reduced risk for pre-eclampsia 
rate, reduced risk for CS, average BMI at delivery and average weight gain (P ≤0.02).
Louie et al.15 
(2011)
• The LGI group had a significantly lower glycaemic load than the HF group (P ≤0.001). 
• No significant difference was detected for average birth weight, rate of macrosomia, rate of LGA, average maternal 
weight gain, rate of insulin treatment and rate of emergency CS (P ≥0.2).
Perichart-
Perera et al.16 
(2009)
• A significant difference was found between control and MNT groups for rate of pre-eclampsia, first maternal hosp- 
italisation rate and neonatal admission rate at intermediate care unit (P ≤0.001). 
• Women in the control group were at a significantly higher risk of having babies with low birth weight (P = 0.041).
Sugiyama et al.17 
(2014)
• No significant difference was found between the intervention and control groups for pregnancy-induced hyper- 
tension, CS or the frequency of LGA and macrosomia (P >0.05). 
• No significant difference was found in neonatal complications (including RDS, hypoglycaemia and jaundice; P >0.05).
Barakat et al.18 
(2013)
• No significant difference was found between the exercise and control groups for requirement of CS, average neonatal 
birth weight, average Apgar score at one minute and the average gestational age in days (P ≥0.2). 
• Rate of macrosomic babies was significantly higher in the control group than the exercise group (P = 0.002).
Artal et al.19 
(2007) 
• 38.6% of DR group subjects were prescribed insulin, while only 35.1% of EDR group subjects needed insulin to 
maintain normal blood glucose levels. 
• There was no significant difference for the mean infant birth weight (P = 0.24). 
• The incidence of CS was similar in the EDR and DR groups (50.0% versus 44.7%). 
• Subjects in both groups who experienced weight gain were at higher risk for having macrosomic babies compared 
to those who had weight loss or no weight change (P = 0.12).
Bo et al.20 
(2014) 
• The DR group showed the highest maternal complications (12%). 
• Neonatal complications were highest among the DR group (10%). 
• Exercise groups (ER and BDER) had the lowest CS rates (17.7% and 16%, respectively). 
• ER group had the lowest rate of LGA (9.8%).
Cao et al.21 
(2012) 
• The intervention group had a significant reduction in rates of premature delivery, admission to NICU and average 
birth weight compared to the control group (P ≤0.05). 
• Although not significant, yet subjects who received intensive treatment had a lower macrosomic rate (P = 0.143). 
• Risk for CS was higher in the intervention group, while the risk of pre-eclampsia was higher in the control group. 
• Percentage receiving insulin treatment was higher in the intervention group (33.9% versus 26.4%).
Yang et al.22 
(2014)
• The control group had a significantly higher rate of macrosomia and LGA than the  intervention group (P ≤0.01). 
• Pre-eclampsia was significantly higher in the intervention group than the control group (P = 0.031). 
• Apgar score <7 was significantly higher in the control group compared to the intervention group (P = 0.02).
Asemi et al.23 
(2015) 
• Women receiving vitamin D supplementation had a significant improvement in relation to the incidence of poly- 
hydramnios, neonatal jaundice and newborn admission compared to the control group (P ≤0.04). 
• No significant difference was found for pre-eclampsia, preterm delivery, macrosomia, need for CS, insulin treatment, 
babies’ gestational age at delivery, Apgar scores at one and five minutes and newborn hypoglycaemia (P ≥0.13).
Lindsay et al.24 
(2015) 
• Probiotic supplementation had no significant effect on improving the maternal metabolic values or improving 
the pregnancy outcomes of women with GDM.
CS = Caesarean section; NICU = neonatal intensive care unit; LGA = large for gestational age; DASH = Dietary Approaches to Stop Hypertension; 
CHO = carbohydrate; BMI = body mass index; LGI = low-glycaemic index; HF = high-fibre; MNT = medical nutrition therapy; RDS = respiratory 
distress syndrome; DR = dietary recommendations only; EDR = exercise and dietary recommendations; ER = exercise recommendations only; 
BDER = behavioural dietary and exercise recommendations; GDM = gestational diabetes mellitus.
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prenatal care (P ≤ 0.01).13 Finally, Sugiyama et al. found 
a significantly lower rate of LGA and lower maternal 
weight gain when comparing diet therapy alone or in 
combination with SMBG and insulin (if needed) with 
the control group that received routine antenatal care.17 
They found that both pre-pregnancy body mass index 
(BMI) and weight gain during pregnancy were indep- 
endently correlated with the incidence of LGA.
Two dietary-based studies were unsuccessful in 
improving any maternal or neonatal outcomes of women 
with GDM.12,15 Moreno-Castilla et al. conducted a study 
in Spain that failed to find a significant difference between 
the low-carbohydrate group and the control diet group in 
terms of the maternal and neonatal outcomes.12 Similarly, 
Louie et al. reported no significant difference between 
the LGI diet group and the HF diet group in relation to 
the incidence of macrosomia, CS, high blood glucose 
levels, glycated haemoglobin (HbA1c) and the need for 
insulin therapy.15
Due to the fact that the reviewed studies imple- 
mented different dietary strategies, reported incons- 
istent results, had diverse population compositions and 
heterogeneous inclusion criteria, a definitive conclusion 
with regard to implementation of dietary strategies could 
not be reached. Additionally, the inclusion of pregnant 
women with various degrees of hyperglycaemia and the 
inconsistency in diagnostic criteria employed for GDM 
diagnosis across these studies further contributes to an 
inability to make informed recommendations on appro- 
priate diets for women with GDM. For example, studies 
used criteria from the American Diabetes Association, 
the 2006 National Diabetes and Pregnancy Clinical Guide- 
lines, World Health Organization, the Australian Diabetes 
in Pregnancy Society and the Society of Obstetrics and 
Gynecology and one study did not clearly state which 
diagnostic criteria was used for GDM diagnosis.10–12,14,15 
Adherence to suggested dietary advice may have 
a considerable impact on the effectiveness of specific 
dietary behaviours. Only one study reported that compl- 
iance to the recommended dietary strategy resulted in 
improved findings.15 Perichart-Perera et al. studied a 
mixed population of women with GDM and women with 
T2DM; however, compliance with the dietary advice 
among the group of women with GDM was not reported, 
making it difficult to evaluate adherence.16 Furthermore, 
women’s interest in the specific dietary advice that they 
received and their readiness to change their dietary 
behaviours were not measured in two unsuccessful studies, 
which may have played a role in the outcomes.12,15 Changing 
dietary behaviours may be challenging, especially during 
the relatively short period of time that is pregnancy. 
Therefore, it is essential to support and encourage women 
with GDM to enhance dietary adherence during the 
new intervention.
The quality of the evidence and the risk of bias 
varied across the reviewed studies. Two of the five 
clinical trials that reported a significant effect on impr- 
oving pregnancy outcomes had a low-to-moderate risk 
of bias and three had a moderate-to-high risk.10,11,13,14,16 
In relation to the studies that were unsuccessful in 
improving pregnancy outcomes in women with GDM, 
one had a low-to-moderate risk of bias and the other 
had a moderate-to-high risk.12,15 Numerous factors may 
have contributed to an increased risk of bias among 
these studies, such as the study design, length of the 
study and the statistical analyses used. Two studies were 
not double-blinded and lacked random assignment of 
subjects to treatment; these findings limit the validity 
of the final outcomes.16,17 
All five clinical trials that reported improved preg- 
nancy outcomes had short intervention periods which 
may have underestimated the true impact of the inter- 
ventions.10,11,13,14,16 Of these, four studies included women 
who were receiving insulin treatment.11,13,14,16 As insulin 
has a hypoglycaemic effect, this may have enhanced the 
effect of the intervention, therefore leading to an over- 
estimation of positive findings. However, both clinical 
trials that reported the intervention group as having 
negative associations with improving pregnancy out-
comes included women on insulin treatment which 
minimises the risk of insulin as a confounding factor.12,15 
Furthermore, none of the studies, except Crowther et al.’s 
study, controlled for the subjects’ demographic charact- 
eristics in their statistical analyses, which may have had 
confounding effects on the outcome and potentially 
increased bias.13 Finally, only two studies clearly stated 
that assumptions related to normality of distribution 
had been checked and both reported significant impr- 
ovements in pregnancy outcomes.10,13 
Effectiveness of Exercise 
Strategy
One double-blinded RCT’s objective was to evaluate 
the effectiveness of regular exercise in reducing the risk 
of GDM-related complications.17 The study found that 
moderate-intensity resistance and aerobic exercise (three 
days/week, 25–30 min/session) had a significant impact 
on reducing macrosomia rates, decreasing the percentage 
of CS and restricting weight gain. More than 95% of 
the subjects were adherent to the training sessions, 
which justifies the significant results. However, this 
study had a moderate-to-high risk of bias. One of the 
potential biases was that the group’s allocation was not 
blinded to the project staff, thus increasing the likeli- 
hood of information bias. Moreover, no mention was 
made of whether statistical assumptions were checked 
and whether potential violations to those assumptions 
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were corrected during analyses. Uncorrected violations 
may have led to incorrect interpretations of the final 
results.
Effectiveness of Dietary and 
Exercise Strategies
Five RCTs examined the efficacy of mixed strategies, 
such as diet in combination with exercise and SMBG, on 
improving maternal and neonatal outcomes in women 
with GDM and their offspring.18–21 Generally, these 
four studies showed a beneficial effect on limiting the 
incidence of at least one GDM-related complication. 
In a non-double-blinded RCT study, Bo et al. found 
that an exercise intervention applied either alone or 
in combination with a behavioural intervention was 
associated with a significant reduction in the incidence 
of CS, HbA1c, postprandial glucose and LGA in comp-
arison to a diet and behavioural intervention alone.20 
Behavioural strategies included oral and written cues 
to encourage the participant to make healthy dietary 
choices. 
Cao et al. demonstrated that an intensive treatment 
regimen resulted in a significantly reduced incidence of 
premature delivery, neonatal admission to the neonatal 
intensive care unit and an average birth weight.21 Comp- 
arably, Yang et al. found that lifestyle interventions 
significantly reduced macrosomia rates, LGA and infant 
Apgar scores less than seven at one minute.22 Never- 
theless, Yang et al.’s study showed that lifestyle interventions 
were significantly associated with increased risk for pre- 
eclampsia. Women who received lifestyle modifications 
(diet and exercise) in this study had a significantly higher 
rate of achieving target physical activity in the previous 
month (30 minutes/time, ≥7 times/week) than the diet 
group alone; however, this finding brings to attention the 
risk involved in overdoing physical activities during 
pregnancy. 
Artal et al.’s study showed that an exercise inter- 
vention limited weight gain among obese GDM women 
but there was no significant difference in gestational 
age at delivery, the need for CS and birth weight.19 
One possible explanation is that Artal et al. considered 
subjects’ preference in assignment to the exercise group, 
possibly justifying the limited weight gain within this 
group. On the other hand, several factors could have 
contributed to the non-significant findings in Artal et al.’s 
study. Missing data for the infant birth weight, gestational 
age at delivery and delivery method in both groups may 
have resulted in biased findings. However, it was found 
that subjects who experienced weight gain were at higher 
risk for having macrosomic babies in comparison to 
those who had weight loss or no weight change.18 
It is important to note that these findings are based 
on limited data generated from RCTs with a moderate-
to-high risk of bias and caution should be taken when 
interpreting their results. The above studies varied in 
their population composition and diagnostic criteria 
used for GDM diagnosis.10–24 In addition, due to the 
nature of the pregnancies, none of these studies had an 
adequate intervention period, which may have led to 
underestimation of study findings. Four studies had a 
risk of bias from insulin treatment administered parallel 
to the study interventions, thereby affecting the validity 
of the results.13,14,16,17 Three studies shared the risk of 
information bias for not blinding outcome assessors, 
thereby potentially increasing the risk of inflated study 
findings.19,20,22 Furthermore, only Bo et al.’s study contr- 
olled for subjects’ ages, baseline metabolic activity and 
pre-pregnancy BMI in their data analysis, which increases 
confidence in their findings.20
In light of the above limitations, the data appear 
to be consistent in reporting low macrosomia rates, 
low LGA and CS rates among women with GDM who 
received lifestyle modifications compared to women 
who received only routine antenatal care.20–22 The evid- 
ence supports the efficacy of dietary strategies combined 
with moderate exercise and SMBG in decreasing the 
incidence of GDM-related complications.
Effectiveness of Dietary 
Supplements Strategies
Studies that examined dietary supplements have demon- 
strated an impact in recommended areas of GDM out- 
comes. Asemi et al.’s double-blinded RCT showed that 
consumption of vitamin D supplements was significantly 
associated with a reduction in the incidence of polyhy- 
dramnios, neonatal jaundice and neonatal admission to 
the neonatal intensive care unit among women with GDM 
compared to patients receiving a placebo supplement.23 
This study was in response to accumulating evidence 
towards an association between abnormal glucose levels 
and vitamin D deficiency. In general, this study had a low- 
to-moderate risk of bias. A potential source of bias was 
the risk for confounding factors since women in the 
control group may have received vitamin D from other 
sources, such as sun exposure and fortified foods. How- 
ever, no significant difference was found between the 
vitamin D and placebo groups in relation to vitamin D 
intake. The serum 25-hydroxyvitamin D level was signif- 
icantly higher among the vitamin D group, indicating a 
low risk of confounding factors. Overall, it appears that 
supplementing the diets of women with GDM with 
vitamin D is promising in reducing GDM-related adverse 
effects.
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The metabolic effects of probiotic supplementation 
has recently been investigated by Lindsay et al. in a double- 
blinded, placebo-controlled RCT.24 This RCT revealed 
that probiotic supplementation did not have a significant 
effect on improving maternal metabolic values or impr- 
oving the pregnancy outcomes for women with GDM. 
This could be due to the high drop-out rate (18%) of the 
RCT after starting the treatment.
Discussion
GDM is a worldwide metabolic problem that has negative 
maternal and neonatal effects with long-term conseq- 
uences. In light of the reviewed literature, various inter- 
ventions have been offered to improve maternal and neo- 
natal outcomes among women with GDM.
Although the majority of the reviewed articles 
were RCTs with powered sample sizes and appropriate 
statistical analyses, most of these studies had method- 
ological issues, such as risk for confounding factors and 
a risk for information bias and contamination. In add- 
ition, samples lacked diversity, with the majority of these 
studies targeting women who are Caucasian.
As the studies in this review do not provide enough 
evidence to guide clinical practice and health policy; well- 
designed double-blinded RCTs are needed to identify 
the best strategies to improve GDM outcomes. Further 
clinical trials should explore the type, intensity and duration 
of exercise that would improve pregnancy outcomes. In 
addition, the effectiveness of probiotics and vitamin D 
supplementation on pregnancy outcomes in women with 
GDM needs to be further studied.
Conclusion
Although the literature is growing in the field of GDM 
management, the incidence rate of GDM-related compl- 
ications continues to rise, most likely due to unhealthy 
lifestyle behaviours. In general, insufficient focus has been 
directed towards the prevention of GDM- related compl- 
ications. Furthermore, there is a lack of evidence about 
the strategies that enhance adherence to healthy lifestyle 
behaviours. The focus of upcoming research should be 
on identifying the factors that enhance and encourage 
adherence to healthy behaviours, such as increased self- 
efficacy towards healthy behaviours.
acknowledgement
The authors would like to thank everyone who supported 
the work in this paper.
References
1. World Health Organization. Diagnostic criteria and classific- 
ation of hyperglycaemia first detected in pregnancy. Geneva: 
World Health Organization. WHO/NMH/ND/13.2. Pp. 1–62. 
2. Nayak PK, Mitra S, Sahoo JP, Daniel M, Mathew A, Padma A. 
Feto-maternal outcomes in women with and without gestational 
diabetes mellitus according to the International Association of 
Diabetes and Pregnancy Study Groups (IADPSG) diagnostic 
criteria. Diabetes Metab Syndr 2013; 7:206–9. https://doi.org/10. 
1016/j.dsx.2013.10.017. 
3. Gasim T. Gestational diabetes mellitus: Maternal and perinatal 
outcomes in 220 Saudi women. Oman Med J 2012; 27:140–4. 
https://doi.org/10.5001/omj.2012.29.
4. Barakat MN, Youssef RM, Al-Lawati JA. Pregnancy outcomes of 
diabetic women: Charting Oman’s progress towards the goals of 
the Saint Vincent Declaration. Ann Saudi Med 2010; 30:265–70. 
https://doi.org/10.4103/0256-4947.65253.
5. Mpondo BC, Ernest A, Dee HE. Gestational diabetes mellitus: 
Challenges in diagnosis and management. J Diabetes Metab 
Disord 2015; 14:42. https://doi.org/10.1186/s40200-015-0169-7.
6. Shriraam V, Rani MA, Sathiyasekaran BW, Mahadevan S. Aware- 
ness of gestational diabetes mellitus among antenatal women 
in a primary health center in South India. Indian J Endocrinol 
Metab 2013; 17:146–8. https://doi.org/10.4103/2230-8210.107861.
7. Mithal A, Bansal B, Kalra S. Gestational diabetes in India: 
Science and society. Indian J Endocrinol Metab 2015; 19:701–4. 
https://doi.org/10.4103/2230-8210.164031.
8. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E. 
Benefits and risks of oral diabetes agents compared with insulin 
in women with gestational diabetes: A systematic review. Obstet 
Gynecol 2009; 113:193–205. https://doi.org/10.1097/AOG.0b0 
13e318190a459.
9. de Holanda VR, de Souza MA, dos Santos Rodrigues MCP, 
Pinheiro AKB, Damasceno MMC. Knowledge of pregnant women 
about gestational diabetes mellitus. J Nurs UFPE Online 2012; 
6:1648–54. 
10. Odar E, Wandabwa J, Kiondo P. Maternal and fetal outcome of 
gestational diabetes mellitus in Mulago Hospital, Uganda. Afr 
Health Sci 2004; 4:9–14.
11. Asemi Z, Samimi M, Tabassi Z, Esmaillzadeh A. The effect of 
DASH diet on pregnancy outcomes in gestational diabetes: 
A randomized controlled clinical trial. Eur J Clin Nutr 2014; 
68:490–5. https://doi.org/10.1038/ejcn.2013.296.
12. Moreno-Castilla C, Hernandez M, Bergua M, Alvarez MC, 
Arce MA, Rodriguez K, et al. Low-carbohydrate diet for the 
treatment of gestational diabetes mellitus: A randomized cont- 
rolled trial. Diabetes Care 2013; 36:2233–8. https://doi.org/10.23 
37/dc12-2714.
13. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, 
Robinson JS, et al. Effect of treatment of gestational diabetes 
mellitus on pregnancy outcomes. N Engl J Med 2005; 352:2477–86. 
https://doi.org/10.1056/NEJMoa042973.
14. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, 
Casey B, et al. A multicenter, randomized trial of treatment for 
mild gestational diabetes. N Engl J Med 2009; 361:1339–48. 
https://doi.org/10.1056/NEJMoa0902430.
15. Louie JC, Markovic TP, Perera N, Foote D, Petocz P, Ross GP, 
et al. A randomized controlled trial investigating the effects of a 
low-glycemic index diet on pregnancy outcomes in gestational 
diabetes mellitus. Diabetes Care 2011; 34:2341–6. https://doi.org/10. 
2337/dc11-0985.
16. Perichart-Perera O, Balas-Nakash M, Parra-Covarrubias A, 
Rodriguez-Cano A, Ramirez-Torres A, Ortega-González C, et al. 
A medical nutrition therapy program improves perinatal out- 
comes in Mexican pregnant women with gestational diabetes 
and type 2 diabetes mellitus. Diabetes Educ 2009; 35:1004–13. 
https://doi.org/10.1177/0145721709343125.
Non-Medical Strategies to Improve Pregnancy Outcomes of Women with Gestational Diabetes Mellitus 
A literature review
e10 | SQU Medical Journal, February 2019, Volume 19, Issue 1
17. Sugiyama T, Metoki H, Hamada H, Nishigori H, Saito M, 
Yaegashi N, et al. A retrospective multi-institutional study of 
treatment for mild gestational diabetes in Japan. Diabetes Res 
Clin Pract 2014; 103:412–18. https://doi.org/10.1016/j.diabres. 
2013.12.017.
18. Barakat R, Pelaez M, Lopez C, Lucia A, Ruiz JR. Exercise during 
pregnancy and gestational diabetes-related adverse effects: A 
randomised controlled trial. Br J Sports Med 2013; 47:630–6. 
https://doi.org/10.1136/bjsports-2012-091788.
19. Artal R, Catanzaro RB, Gavard JA, Mostello DJ, Friganza JC. A 
lifestyle intervention of weight-gain restriction: Diet and exercise 
in obese women with gestational diabetes mellitus. Appl Physiol 
Nutr Metab 2007; 32:596–601. https://doi.org/10.1139/H07-024.
20. Bo S, Rosato R, Ciccone G, Canil S, Gambino R, Poala CB, 
et al. Simple lifestyle recommendations and the outcomes of 
gestational diabetes. A 2 × 2 factorial randomized trial. Diabetes 
Obes Metab 2014; 16:1032–5. https://doi.org/10.1111/dom.12289.
21. Cao X, Wang Z, Yang C, Mo X, Xiu L, Li Y, et al. Comprehensive 
intensive therapy for Chinese gestational diabetes benefits both 
newborns and mothers. Diabetes Technol Ther 2012; 14:1002–7. 
https://doi.org/10.1089/dia.2012.0142.
22. Yang X, Tian H, Zhang F, Zhang C, Li Y, Leng J, et al. A rando- 
mized translational trial of lifestyle intervention using a 3-tier 
shared care approach on pregnancy outcomes in Chinese women 
with gestational diabetes mellitus but without diabetes. J Transl 
Med 2014; 12:290. https://doi.org/10.1186/s12967-014-0290-2.
23. Asemi Z, Karamali M, Esmaillzadeh A. Favorable effects of vita- 
min D supplementation on pregnancy outcomes in gestational 
diabetes: A double blind randomized controlled clinical trial. 
Horm Metab Res 2015; 47:565–70. https://doi.org/10.1055/s-00 
34-1394414. 
24. Lindsay KL, Brennan L, Kennelly MA, Maguire OC, Smith T, 
Curran S, et al. Impact of probiotics in women with gestational 
diabetes mellitus on metabolic health: A randomized controlled 
trial. Am J Obstet Gynecol 2015; 212:496.e1–11. https://doi.org/10. 
1016/j.ajog.2015.02.008.
